SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-23-036792
Filing Date
2023-11-03
Accepted
2023-11-03 17:23:42
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 forms-311x03x2023.htm S-3 501161
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 49507
3 EX-1.2 exhibit12-sx3.htm EX-1.2 280479
4 EX-4.5 exhibit45-sx3.htm EX-4.5 348669
5 EX-4.6 exhibit46-sx3.htm EX-4.6 351157
6 EX-5.1 exhibit51-sx3.htm EX-5.1 15506
7 EX-5.2 exhibit52-sx3.htm EX-5.2 7584
8 EX-23.1 exhibit231-sx3.htm EX-23.1 1817
9 image.jpg GRAPHIC 29471
  Complete submission text file 0001628280-23-036792.txt   1597527
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275321 | Film No.: 231377419
SIC: 2836 Biological Products, (No Diagnostic Substances)